Compare Mesoblast Limited (MESO) vs Public Storage (PSA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Public Storage — how do they compare? Mesoblast Limited trades at $16.36 (market cap $2.17B), while Public Storage trades at $312.89 (market cap $55.40B). The key difference: Public Storage is far larger — about 25.5× Mesoblast Limited's market cap, and Public Storage pays a 3.8% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | PSA | |
|---|---|---|
Market Cap | $2.17B | $55.40B |
Sector | Technology | Real Estate |
52-Week High | $20.96 | $329.64 |
52-Week Low | $12.88 | $258.44 |
Enterprise Value | $2.17B | $69.65B |
Dividend Yield | — | 3.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MESO trades at $16.63, down 3.98% on the day, with a bullish technical outlook supported by moving averages. The company shows strong revenue growth with Ryoncil generating $115 million in annual revenue, though it remains unprofitable with a net loss of $102 million. Recent developments include positive Phase 3 trial progress and FDA BLA filings for new treatments.
Investment outlook balances promising pipeline progress against significant financial losses. The stock offers growth potential through commercial expansion but carries substantial risk from continued cash burn and regulatory hurdles. Analyst consensus leans bullish with 45% buy ratings, reflecting optimism about the company's transition to commercial-stage operations.
Public Storage (PSA) trades at $315.45, down 0.81% on the day, with a neutral technical signal and mixed moving averages. The company shows strong profitability with 39.16% net income margin and 33.78% ROE, though valuation ratios appear elevated with P/E of 32.86. Recent developments include the pending acquisition of National Storage Affiliates and consistent earnings beats in recent quarters.
The outlook remains cautiously optimistic with a $332.25 consensus price target representing 5.3% upside. Key opportunities include expansion into Canadian markets and operational efficiencies, while risks involve integration challenges from acquisitions and potential interest rate sensitivity. Analyst consensus leans neutral with 65.72% hold ratings amid valuation concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →
